Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costsfinancialpost.com1d agoRead at financialpost.comEarlier from this sourceMISSION SUCCESS: Rocket Lab Launches 96th Electron Mission17h agoCollective Metals Announces Management Changes21h agoLiberty Gold Files Feasibility Study Technical Report for the Black Pine Project in Idaho, USA22h agoAjax library workers reject two-tier contract: ‘We need a fair deal for everyone’22h agoGreenland Mines Applauds Historic U.S.-Denmark-Greenland Security Agreement, Reinforcing Greenland’s Strategic Importance to the United States23h agoOttawa’s ‘mega deduction’ tax write-off could boost these TSX stocks, analysts say1d agoNews of the day: The antagonist next door, variable-rate’s moment, how high will interest rates go, workplace investigations, dual-citizen taxes and more1d agoPIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Closed End Funds1d agoHow this page changedShareSign in to saveLink